Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 2 (2005), Issue 4 (April)

1. Transgene delivery and gelonin cytotoxicity enhanced by photochemical internalization in fibroblast-like synoviocytes (FLS) from rheumatoid arthritis patients.
   Photochem Photobiol Sci, 4(4): 341-7. [Abstract] [Full-text]
2. Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletion.
   Acta Haematol, 113(2): 146-9. [Abstract] [Full-text]
3. Macrophage activation syndrome in children with systemic-onset juvenile chronic arthritis.
   Acta Haematol, 113(2): 124-9. [Abstract] [Full-text]
4. Synovial pathology in camptodactyly-arthropathy-coxa vara-pericarditis syndrome.
   Pediatr Dev Pathol, 8(1): 26-33. [Abstract] [Full-text]
5. Long-term results of the modified Hoffman procedure in the rheumatoid forefoot.
   J Bone Joint Surg Am, 87(4): 748-52. [Abstract] [Full-text]
6. Visual outcome of juvenile rheumatoid arthritis-associated uveitis in adults.
   Ocul Immunol Inflamm, 13(1): 33-8. [Abstract] [Full-text]
7. Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy.
   Cytokine, 30(2): 72-7. [Abstract] [Full-text]
8. Ocular manifestations of juvenile rheumatoid arthritis in Olmsted County, Minnesota: a population-based study.
   Graefes Arch Clin Exp Ophthalmol, 243(3): 217-21. [Abstract] [Full-text]
9. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis.
   Clin Exp Immunol, 140(2): 360-7. [Abstract] [Full-text]
10. New therapies for rheumatoid arthritis.
    Clin Exp Immunol, 140(2): 195-204. [Abstract] [Full-text]
11. Treatment of refractory autoimmune diseases with autologous stem cell transplantation: focus on juvenile idiopathic arthritis.
    Bone Marrow Transplant, 35: S27-9. [Abstract] [Full-text]
12. Periodontal infection as a possible severity factor for rheumatoid arthritis.
    J Clin Periodontol, 32(4): 412-6. [Abstract] [Full-text]
13. Early activation of cutaneous vessels and epithelial cells is characteristic of acute systemic onset juvenile idiopathic arthritis.
    Exp Dermatol, 14(4): 259-65. [Abstract] [Full-text]
14. Extraintestinal manifestations of Crohn's disease.
    Digestion, 71(1): 31-6. [Abstract] [Full-text]
15. Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids.
    Clin Rheumatol, 24(2): 129-33. [Abstract] [Full-text]
16. The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity.
    Clin Rheumatol, 24(2): 123-8. [Abstract] [Full-text]
17. Health-related quality of life in rheumatoid arthritis in Northern Sweden: a comparison between patients with early RA, patients with medium-term disease and controls, using SF-36.
    Clin Rheumatol, 24(2): 117-22. [Abstract] [Full-text]
18. Transition of the adolescent patient with rheumatic disease: issues to consider.
    Pediatr Clin North Am, 52(2): 641-52, viii. [Abstract] [Full-text]
19. Pediatric pain syndromes and management of pain in children and adolescents with rheumatic disease.
    Pediatr Clin North Am, 52(2): 611-39, vii. [Abstract] [Full-text]
20. Juvenile idiopathic arthritis.
    Pediatr Clin North Am, 52(2): 413-42, vi. [Abstract] [Full-text]
21. Measurement of health status, functional status, and quality of life in children with juvenile idiopathic arthritis: clinical science for the pediatrician.
    Pediatr Clin North Am, 52(2): 359-72, v. [Abstract] [Full-text]
22. Inflammation in juvenile idiopathic arthritis.
    Pediatr Clin North Am, 52(2): 335-57, v. [Abstract] [Full-text]
23. Sjögren's syndrome.
    Eur J Oral Sci, 113(2): 101-13. [Abstract] [Full-text]
24. Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis.
    J Pathol, 206(1): 17-27. [Abstract] [Full-text]
25. Cutaneous Scedosporium apiospermum infection in an immunocompromised patient and a review of the literature.
    Acta Derm Venereol, 85(2): 156-9. [Abstract] [Full-text]
26. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.
    Clin Ther, 26(12): 1960-75. [Abstract] [Full-text]
27. TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma.
    Autoimmun Rev, 4(3): 153-61. [Abstract] [Full-text]
28. Epidemiology of adult rheumatoid arthritis.
    Autoimmun Rev, 4(3): 130-6. [Abstract] [Full-text]
29. Primary Sjogren's syndrome presenting as a generalized chorea.
    Parkinsonism Relat Disord, 11(3): 193-4. [Abstract] [Full-text]
30. Delayed response to anti-tuberculosis treatment in a patient on infliximab.
    Respir Med, 99(5): 648-52. [Abstract] [Full-text]
31. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
    Arthritis Rheum, 53(2): 234-40. [Abstract] [Full-text]
32. Need for information and for involvement in decision making among patients with rheumatoid arthritis: a questionnaire survey.
    Arthritis Rheum, 53(2): 249-55. [Abstract] [Full-text]
33. Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab.
    Arthritis Rheum, 52(4): 1224-6. [Abstract] [Full-text]
34. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985.
    Arthritis Rheum, 52(4): 1009-19. [Abstract] [Full-text]
35. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Arthritis Rheum, 52(4): 1081-90. [Abstract] [Full-text]
36. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
    Arthritis Rheum, 52(4): 1205-15. [Abstract] [Full-text]
37. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.
    Arthritis Rheum, 52(4): 1031-6. [Abstract] [Full-text]
38. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
    Arthritis Rheum, 52(4): 1020-30. [Abstract] [Full-text]
39. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept.
    Arthritis Rheum, 52(4): 1216-23. [Abstract] [Full-text]
40. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort.
    Arthritis Rheum, 52(4): 1138-47. [Abstract] [Full-text]
41. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine.
    Arthritis Rheum, 52(4): 1037-46. [Abstract] [Full-text]
42. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.
    Arthritis Rheum, 52(4): 1185-95. [Abstract] [Full-text]
43. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese.
    Arthritis Rheum, 52(4): 1058-62. [Abstract] [Full-text]
44. Reduced p53 in peripheral blood mononuclear cells from patients with rheumatoid arthritis is associated with loss of radiation-induced apoptosis.
    Arthritis Rheum, 52(4): 1047-57. [Abstract] [Full-text]
45. New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility.
    Arthritis Rheum, 52(4): 1063-8. [Abstract] [Full-text]
46. Pain, stiffness, and fatigue in juvenile polyarticular arthritis: contemporaneous stressful events and mood as predictors.
    Arthritis Rheum, 52(4): 1196-204. [Abstract] [Full-text]
47. Gaps in care for rheumatoid arthritis: a population study.
    Arthritis Rheum, 53(2): 241-8. [Abstract] [Full-text]
48. Impact of ultrasound imaging on local corticosteroid injections of symptomatic ankle, hind-, and mid-foot in chronic inflammatory diseases.
    Arthritis Rheum, 53(2): 284-92. [Abstract] [Full-text]
49. Relationship of pain-coping strategies and pain-specific beliefs to pain experience in children with juvenile idiopathic arthritis.
    Arthritis Rheum, 53(2): 178-84. [Abstract] [Full-text]
50. Leflunomide reduces nitric oxide production in patients with active rheumatoid arthritis.
    Int Immunopharmacol, 5(6): 1085-90. [Abstract] [Full-text]
51. Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein.
    J Clin Pharmacol, 45(5): 490-7. [Abstract] [Full-text]
52. Implication of interleukin 18 in production of matrix metalloproteinases in articular chondrocytes in arthritis: direct effect on chondrocytes may not be pivotal.
    Ann Rheum Dis, 64(5): 735-42. [Abstract] [Full-text]
53. The role of substance P in microvascular responses in murine joint inflammation.
    Br J Pharmacol, 144(8): 1059-66. [Abstract] [Full-text]
54. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas.
    Ann Rheum Dis, 64(5): 699-703. [Abstract] [Full-text]
55. Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis.
    Ann Rheum Dis, 64(5): 722-9. [Abstract] [Full-text]
56. Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care.
    Ann Rheum Dis, 64(5): 659-63. [Abstract] [Full-text]
57. Expression and regulation of cryopyrin and related proteins in rheumatoid arthritis synovium.
    Ann Rheum Dis, 64(5): 708-14. [Abstract] [Full-text]
58. Toll-like receptor 4 gene polymorphisms and susceptibility to juvenile idiopathic arthritis.
    Ann Rheum Dis, 64(5): 767-9. [Abstract] [Full-text]
59. beta2 Adrenoceptor gene single nucleotide polymorphisms are associated with rheumatoid arthritis in northern Sweden.
    Ann Rheum Dis, 64(5): 773-6. [Abstract] [Full-text]
60. Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis.
    Ann Rheum Dis, 64(5): 704-7. [Abstract] [Full-text]
61. Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis.
    Ann Rheum Dis, 64(5): 715-21. [Abstract] [Full-text]
62. Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging.
    Ann Rheum Dis, 64(5): 730-4. [Abstract] [Full-text]
63. Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis.
    Ann Rheum Dis, 64(5): 765-6. [Abstract] [Full-text]
64. Ultrasonographic contrast-enhanced study of sicca syndrome.
    Eur J Radiol, 54(2): 225-32. [Abstract] [Full-text]
65. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt.
    J Biol Chem, 280(16): 15709-18. [Abstract] [Full-text]
66. Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis.
    Rheumatology (Oxford), 44(5): 677-80. [Abstract] [Full-text]
67. Validity and reliability of an Italian version of the revised Leeds disability questionnaire for patients with ankylosing spondylitis.
    Rheumatology (Oxford), 44(5): 666-9. [Abstract] [Full-text]
68. Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years.
    Rheumatology (Oxford), 44(5): 670-6. [Abstract] [Full-text]
69. Clinical characteristics of an anatomical hand index measured in patients with rheumatoid arthritis as a potential outcome measure.
    Rheumatology (Oxford), 44(5): 651-5. [Abstract] [Full-text]
70. Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria.
    Rheumatology (Oxford), 44(5): 629-32. [Abstract] [Full-text]
71. Patient-assessed health in ankylosing spondylitis: a structured review.
    Rheumatology (Oxford), 44(5): 577-86. [Abstract] [Full-text]
72. Leflunomide or methotrexate for juvenile rheumatoid arthritis.
    N Engl J Med, 352(16): 1655-66. [Abstract] [Full-text]
73. Soluble transferrin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis.
    Clin Chem Lab Med, 43(3): 326-31. [Abstract] [Full-text]
74. Rheumatoid arthritis and pigmented villonodular synovitis: comparative analysis of cell polyploidy, cell cycle phases and expression of macrophage and fibroblast markers in proliferating synovial cells.
    Histopathology, 46(5): 490-7. [Abstract] [Full-text]
75. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    Am J Gastroenterol, 100(5): 1043-50. [Abstract] [Full-text]
76. Rheumatoid nodules without arthritis.
    Australas J Dermatol, 46(2): 93-6. [Abstract] [Full-text]
77. Sulfasalazine for ankylosing spondylitis.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
78. Health-related quality of life predicts future health care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: the veterans arthritis quality of life study.
    Semin Arthritis Rheum, 34(5): 755-65. [Abstract] [Full-text]
79. Radiation exposure in rheumatology practice.
    Semin Arthritis Rheum, 34(5): 750-4. [Abstract] [Full-text]
80. Immunogenetics of primary Sjögren's syndrome in Colombians.
    Semin Arthritis Rheum, 34(5): 735-43. [Abstract] [Full-text]
81. Ayurvedic medicine for rheumatoid arthritis: a systematic review.
    Semin Arthritis Rheum, 34(5): 705-13. [Abstract] [Full-text]
82. Apolipoprotein A-I-dependent cholesterol esterification in patients with rheumatoid arthritis.
    Life Sci, 77(1): 108-20. [Abstract] [Full-text]
83. P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome.
    Arch Oral Biol, 50(6): 533-40. [Abstract] [Full-text]
84. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.
    J Autoimmun, 24(3): 235-42. [Abstract] [Full-text]
85. What are the links between Epstein-Barr virus, lymphoma, and tumor necrosis factor antagonism in rheumatoid arthritis?
    Semin Arthritis Rheum, 34(5): 31-3. [Abstract] [Full-text]
86. Diverse effects of infliximab and etanercept on T lymphocytes.
    Semin Arthritis Rheum, 34(5): 23-7. [Abstract] [Full-text]
87. B cells in rheumatoid arthritis: from hypothesis to the clinic.
    Rheumatology (Oxford), 44: ii8-ii12. [Abstract] [Full-text]
88. B cells: a fundamental role in the pathogenesis of rheumatoid arthritis?
    Rheumatology (Oxford), 44: ii3-ii7. [Abstract] [Full-text]
89. Panel discussion on B cells and rituximab: mechanistic aspects, efficacy and safety in rheumatoid arthritis and non-Hodgkin's lymphoma.
    Rheumatology (Oxford), 44: ii18-ii20. [Abstract] [Full-text]
90. Aseptic discitis in patients with ankylosing spondylitis: a retrospective study of 14 cases.
    Joint Bone Spine, 72(3): 248-53. [Abstract] [Full-text]
91. Asymmetry of small joint involvement in rheumatoid arthritis: prevalence and tendency towards symmetry over time.
    Joint Bone Spine, 72(3): 241-7. [Abstract] [Full-text]
92. Structural evaluation in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion.
    Joint Bone Spine, 72(3): 229-34. [Abstract] [Full-text]
93. Physical examination and laboratory tests in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion.
    Joint Bone Spine, 72(3): 222-8. [Abstract] [Full-text]
94. Reversible cortical lesions in primary Sjögren's syndrome presenting with meningoencephalitis as an initial manifestation.
    J Neurol Sci, 232(1): 111-3. [Abstract] [Full-text]
95. Shoulder hemiarthroplasty in patients with juvenile idiopathic arthritis.
    J Bone Joint Surg Br, 87(5): 672-6. [Abstract] [Full-text]
96. Candida albicans cell-wall fraction exacerbates collagen-induced arthritis in mice.
    Scand J Immunol, 61(4): 301-8. [Abstract] [Full-text]
97. Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients.
    Genes Immun, 6(3): 211-6. [Abstract] [Full-text]
98. A case of autoimmune pancreatitis associated with sclerosing cholangitis, retroperitoneal fibrosis and Sjögren's syndrome.
    Pancreatology, 5(1): 86-91. [Abstract] [Full-text]
99. CUL1, a component of E3 ubiquitin ligase, alters lymphocyte signal transduction with possible effect on rheumatoid arthritis.
    Genes Immun, 6(3): 194-202. [Abstract] [Full-text]
100. Skewed T-cell receptor BV14 and BV16 expression and shared CDR3 sequence and common sequence motifs in synovial T cells of rheumatoid arthritis.
     Genes Immun, 6(3): 248-61. [Abstract] [Full-text]
101. Well-being in rheumatoid arthritis: the effects of disease duration and psychosocial factors.
     J Health Psychol, 10(3): 457-74. [Abstract] [Full-text]
102. Adult-onset Still's disease with atypical cutaneous features.
     J Eur Acad Dermatol Venereol, 19(3): 360-3. [Abstract] [Full-text]
103. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.
     Nat Genet, 37(5): 478-85. [Abstract] [Full-text]
104. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
     Nat Genet, 37(5): 486-94. [Abstract] [Full-text]
105. FK506 suppresses the stimulation of matrix metalloproteinase 13 synthesis by interleukin-1beta in rheumatoid synovial fibroblasts.
     Immunol Lett, 98(2): 194-9. [Abstract] [Full-text]
106. Novel monoclonal antibodies detect elevated levels of the chemokine CCL18/DC-CK1 in serum and body fluids in pathological conditions.
     J Leukoc Biol, 77(5): 739-47. [Abstract] [Full-text]

© 2004-2008 Rheumatoid Arthritis Research Today. All Rights Reserved.